Back to the drug test guide

Fentanyl Test Evidence

Has Caused a False Positive

Ciprofloxacin

Source Fitch et al., Clin Chem 2023

What It Found

  • Clinical samples with unconfirmed fentanyl screens contained ciprofloxacin.
  • Spiked urine turned positive above 40 micrograms/mL, a level observed in five of six false-positive specimens evaluated for ciprofloxacin.

Keep in Mind

  • This evidence concerns the ARK II reagent.
  • A negative experiment on a different drug-test panel does not rule this out.

Test Studied

  • ARK Fentanyl II, 1 ng/mL cutoff

Dextromethorphan

Source LZI Fentanyl Enzyme Immunoassay, FDA 510(k) decision summary K181159, 2018

What It Found

  • The earlier reagent produced a positive with 40,000 ng/mL dextromethorphan in drug-free urine.

Test Studied

  • Lin-Zhi LZI fentanyl EIA (K181159)

Source Uljon et al., J Appl Lab Med 2024

What It Found

  • In a later Lin-Zhi II study, two people with known dextromethorphan exposure had unconfirmed low-positive screens.

Keep in Mind

  • The clinical study considered dextromethorphan a likely explanation.
  • One exposure was an overdose.

Test Studied

  • A later Lin-Zhi Fentanyl II study

Both sources LZI Fentanyl Enzyme Immunoassay, FDA 510(k) decision summary K181159, 2018 Uljon et al., J Appl Lab Med 2024

Keep in Mind

  • Neither study estimates risk at labeled cough doses.

Haloperidol

Source Wang et al., Drug Alcohol Depend 2024

What It Found

  • Haloperidol was among three drugs implicated in clinical samples and verified by spiking urine.

Source Immunalysis SEFRIA Fentanyl Urine Enzyme Immunoassay, FDA 510(k) decision summary K161216, 2017

What It Found

  • The FDA decision summary also documents a positive result with added haloperidol.

Both sources Wang et al., Drug Alcohol Depend 2024 Immunalysis SEFRIA Fentanyl Urine Enzyme Immunoassay, FDA 510(k) decision summary K161216, 2017

Keep in Mind

  • Evidence concerns the specific SEFRIA method.
  • A personal chance of a false positive was not measured.

Test Studied

  • Immunalysis SEFRIA

Methamphetamine

Source Abbott et al., J Anal Toxicol 2022

What It Found

  • A forensic laboratory traced a series of unexpected screens to urine methamphetamine above 40 micrograms/mL on the Neogen assay.

Test Studied

  • Neogen urine fentanyl ELISA at 1 ng/mL

Source Immunalysis SEFRIA Fentanyl Urine Enzyme Immunoassay, FDA 510(k) decision summary K161216, 2017

What It Found

  • The SEFRIA submission also reports reactivity at 70 micrograms/mL.

Test Studied

  • SEFRIA analytical challenge

Both sources Abbott et al., J Anal Toxicol 2022 Immunalysis SEFRIA Fentanyl Urine Enzyme Immunoassay, FDA 510(k) decision summary K161216, 2017

Keep in Mind

  • The finding concerns high urine concentrations.
  • Testing drug powders with a fentanyl strip is a separate application.

Ofloxacin

Source Fitch et al., Clin Chem 2023

What It Found

  • Desmethyl-ofloxacin produced a positive signal at a concentration found in clinical specimens.
  • Ofloxacin itself produced a partial response and the N-oxide metabolite did not react.

Keep in Mind

  • These findings concern urine concentrations associated with systemic exposure.
  • Eye and ear preparations were not assessed.

Test Studied

  • ARK Fentanyl II, 1 ng/mL cutoff

Paliperidone

2 sources Wang et al., J Anal Toxicol 2014 Li et al., Clin Chem 2020

What It Found

  • Paliperidone is 9-hydroxyrisperidone and reacted in laboratory testing.

Source False-positive fentanyl urine screening during treatment with paliperidone: a case report, 2026

What It Found

  • A patient receiving paliperidone screened positive, with neither fentanyl nor its metabolites detected on follow-up LC-MS/MS.

Test Studied

  • A separate clinical urine case

All 3 sources Wang et al., J Anal Toxicol 2014 Li et al., Clin Chem 2020 False-positive fentanyl urine screening during treatment with paliperidone: a case report, 2026

Keep in Mind

  • The direct paliperidone case and studies of the risperidone metabolite do not establish a frequency across assays or formulations.

Source Wang et al., J Anal Toxicol 2014

Test Studied

  • Thermo DRI

Source Li et al., Clin Chem 2020

Test Studied

  • A research lateral-flow assay

Risperidone

Source Wang et al., J Anal Toxicol 2014

What It Found

  • Five of seven DRI false positives contained risperidone and its active metabolite.
  • Reagent testing confirmed reactivity.

Test Studied

  • Thermo DRI

Source Shroitman et al., Psychiatry Res 2021

What It Found

  • Additional reports include three patients taking long-acting injectable risperidone.

3 sources Wang et al., J Anal Toxicol 2014 Li et al., Clin Chem 2020 Immunalysis SEFRIA Fentanyl Urine Enzyme Immunoassay, FDA 510(k) decision summary K161216, 2017

Keep in Mind

  • The reaction depends on the kit and the concentration of parent drug and metabolites.

Trazodone

Source Wang et al., Drug Alcohol Depend 2024

What It Found

  • Trazodone was identified in the hospital's investigation of unconfirmed fentanyl screens.
  • Spiking experiments reproduced interference.

Keep in Mind

  • The study identified three major interferents together.
  • Its percentages do not measure an individual trazodone user's risk.

Source Immunalysis SEFRIA Fentanyl Urine Enzyme Immunoassay, FDA 510(k) decision summary K161216, 2017

What It Found

  • The original submission also found reactivity with high concentrations of the metabolite mCPP.

Depends on the Brand of Test

Labetalol

Source Wang et al., Drug Alcohol Depend 2024

What It Found

  • A hospital investigation found labetalol among the major interferents and reproduced interference by spiking.

Source Wanar et al., J Addict Med 2022

What It Found

  • Three pregnant or recently pregnant patients also had presumptive fentanyl positives while taking it.

Keep in Mind

  • Review labor analgesia as a separate possible source of true fentanyl.

Test Studied

  • Separate perinatal urine case series

Source Hightop Fentanyl/Norfentanyl Urine Rapid Test Panel and home-use panel, FDA 510(k)…, 2024

Keep in Mind

  • Hightop’s fentanyl line did not turn positive with labetalol at 100,000 ng/mL in its validation.

Loperamide

Both sources Geno et al., J Appl Lab Med 2022 Walsh et al., J Appl Lab Med 2025

What It Found

  • At high concentrations, loperamide and its N-desmethyl metabolite triggered the first three assays.

Keep in Mind

  • The studies do not show an ordinary antidiarrheal dose commonly causes this.

Test Studied

  • Thermo DRI, Immunalysis HEIA and SEFRIA

Source Walsh et al., J Appl Lab Med 2025

What It Found

  • The other three were negative under the follow-up study conditions.

Test Studied

  • Comparative Abbott iCassette, ARK Fentanyl II and LZI II

Source Geno et al., J Appl Lab Med 2022

What It Found

  • One patient specimen had enough loperamide-related material to explain the initial result.

Keep in Mind

  • In the 2022 series, four of five samples containing loperamide or its metabolite also contained fentanyl.

Alfentanil

Source Hightop Fentanyl/Norfentanyl Urine Rapid Test Panel and home-use panel, FDA 510(k)…, 2024

What It Found

  • The related anesthetic alfentanil produced a positive at 10,000 ng/mL in the device's spiking study.

Keep in Mind

  • This laboratory concentration and test-specific result do not establish an incidence after surgical anesthesia.

Test Studied

  • Hightop rapid urine panel, fentanyl line at 1 ng/mL

Source Wolf et al., Clin Biochem 2025

What It Found

  • None of the four reagents detected added Alfentanil in the study’s series tested at 1, 10 and 100 ng/mL.

Keep in Mind

  • This addresses the parent drug over the tested concentration range.
  • Results need not extend to other reagents or metabolites.

Test Studied

  • ARK Fentanyl II, Immunalysis Fentanyl Urine HEIA, Immunalysis SEFRIA, and Lin-Zhi Fentanyl II

Source Mao et al., J Pharm Biomed Anal 2006

What It Found

  • The experimental antibody showed less than 1% relative response to Alfentanil.

Keep in Mind

  • The abstract does not separately identify a urine matrix for the binding measurement.
  • This is analytical evidence for the antibody, not a patient result.

Test Studied

  • Experimental competitive anti-fentanyl ELISA evaluated for serum and urine

Sufentanil

Source Hightop Fentanyl/Norfentanyl Urine Rapid Test Panel and home-use panel, FDA 510(k)…, 2024

What It Found

  • Sufentanil, an opioid anesthetic related to fentanyl, produced a positive at 1,000 ng/mL in the device's spiking study.

Keep in Mind

  • The parent-drug challenge did not establish how often the given concentration is reached after clinical use.
  • The assay challenge did not establish how often the concentration is reached after clinical use.

Test Studied

  • Hightop rapid urine panel, fentanyl line at 1 ng/mL

Source Williams et al., Clin Biochem 2023

What It Found

  • Neither reagent detected norsufentanil, a metabolite of sufentanil, in the studied series up to 100 ng/mL.

Test Studied

  • ARK Fentanyl II and Immunalysis SEFRIA

Source Wolf et al., Clin Biochem 2025

What It Found

  • The four reagents did not detect the metabolite norsufentanil in the 1–100 ng/mL challenge series.

Test Studied

  • ARK Fentanyl II, Immunalysis Fentanyl Urine HEIA, Immunalysis SEFRIA, and Lin-Zhi Fentanyl II

Source Mao et al., J Pharm Biomed Anal 2006

What It Found

  • The experimental antibody showed less than 1% relative response to Sufentanil.

Keep in Mind

  • The abstract does not separately identify a urine matrix for the binding measurement.
  • This is analytical evidence for the antibody, not a patient result.

Test Studied

  • Experimental competitive anti-fentanyl ELISA evaluated for serum and urine

2 sources Williams et al., Clin Biochem 2023 Wolf et al., Clin Biochem 2025

Keep in Mind

  • The negative challenges apply only to norsufentanil, a distinct metabolite.

A Related Drug the Test Picks Up

Butyrylfentanyl

Source Cole et al., Pediatrics 2015

What It Found

  • A patient's urine screened positive for fentanyl during a reported butyrfentanyl overdose.

Keep in Mind

  • This single case does not provide a reagent-specific threshold or prove performance on other fentanyl tests.

Test Studied

  • Hospital urine fentanyl screen in a published overdose case

3 methylthienylfentanyl

Source Mao et al., J Pharm Biomed Anal 2006

What It Found

  • The experimental antibody showed 100% relative response to 3 methylthienylfentanyl.

Keep in Mind

  • The abstract does not separately identify a urine matrix for the binding measurement.
  • This is analytical evidence for the antibody, not a patient result.

Test Studied

  • Experimental competitive anti-fentanyl ELISA evaluated for serum and urine

Acetylfentanyl

2 sources Wang et al., J Anal Toxicol 2014 Immunalysis SEFRIA Fentanyl Urine Enzyme Immunoassay, FDA 510(k) decision summary K161216, 2017

What It Found

  • Acetylfentanyl is a related synthetic opioid that can produce a positive fentanyl screen even when fentanyl itself is absent.

Keep in Mind

  • This is an analogue exposure, distinct from interference by an unrelated prescribed medicine.
  • The confirmation panel must include the relevant analogue to identify it.

Source Wegner and Tiscione, American Academy of Forensic Sciences Annual Scientific Meeting, abstract K14 2015

What It Found

  • The study team's 2015 validation abstract reports 50–59% reactivity for acetylfentanyl in urine spiked at 5, 10 and 25 ng/mL.

2 sources Tiscione and Wegner, J Anal Toxicol 2017 Wegner and Tiscione, American Academy of Forensic Sciences Annual Scientific Meeting, abstract K14 2015

Keep in Mind

  • The exact urine percentages come from the conference report.
  • They should not be assigned to all six compounds named in the final paper.

Test Studied

  • Neogen fentanyl RTU ELISA in fortified human urine

Source Wang et al., J Anal Toxicol 2014

Test Studied

  • Thermo DRI

Carfentanil

Source Mao et al., J Pharm Biomed Anal 2006

What It Found

  • The experimental antibody showed 85% relative response to Carfentanil.

Keep in Mind

  • The abstract does not separately identify a urine matrix for the binding measurement.
  • This is analytical evidence for the antibody, not a patient result.

Test Studied

  • Experimental competitive anti-fentanyl ELISA evaluated for serum and urine

Methylacetylfentanyl isomers

Source Barajas et al., J Appl Lab Med 2025

What It Found

  • Ortho-, meta- and para-methylacetylfentanyl cross-reacted with the urine immunoassay in a proficiency challenge and shared signals with fentanyl in one mass spectrometry method.

Keep in Mind

  • These are fentanyl analogues rather than routine medicines.
  • The laboratory developed additional chemical markers to distinguish the isomers from fentanyl.

Test Studied

  • ARK Fentanyl II and a specific LC-MS/MS fentanyl method

para-Fluorofentanyl

Source Mao et al., J Pharm Biomed Anal 2006

What It Found

  • The experimental antibody showed 100% relative response to para-Fluorofentanyl.

Keep in Mind

  • The abstract does not separately identify a urine matrix for the binding measurement.
  • This is analytical evidence for the antibody, not a patient result.

Test Studied

  • Experimental competitive anti-fentanyl ELISA evaluated for serum and urine

Thienylfentanyl

Source Mao et al., J Pharm Biomed Anal 2006

What It Found

  • The experimental antibody showed 100% relative response to Thienylfentanyl.

Keep in Mind

  • The abstract does not separately identify a urine matrix for the binding measurement.
  • This is analytical evidence for the antibody, not a patient result.

Test Studied

  • Experimental competitive anti-fentanyl ELISA evaluated for serum and urine

The Test Is Made to Find It

Fentanyl

2 sources Li et al., Clin Chem 2020 Stolbach et al., J Med Toxicol 2022

What It Found

  • Medically administered fentanyl can give a genuine fentanyl result.

Tests Studied

  • Fentanyl-specific urine immunoassay
  • LC-MS/MS identifies parent drug or norfentanyl

Source Stolbach et al., J Med Toxicol 2022

What It Found

  • The laboratory can compare the detected analytes with the medication and anesthesia record.

Keep in Mind

  • A urine result alone does not specify the source, route, impairment or intent.

Source Siegel et al., Am J Obstet Gynecol 2023

What It Found

  • Fentanyl in a labor epidural has produced true positives in maternal and neonatal urine.

Source Makowski et al., Ann Clin Lab Sci 1995

What It Found

  • The assay detected fentanyl in urine from surgical patients receiving the drug.
  • Its antibody responded less to norfentanyl than to fentanyl.

Keep in Mind

  • The tested ELISA predates the current commercial platforms.

Test Studied

  • Historical fentanyl-specific urine ELISA

Source Williams et al., Clin Biochem 2023

What It Found

  • Norfentanyl showed approximately 7% relative reactivity with ARK II and 0.005% with the SEFRIA method studied.

Keep in Mind

  • The metabolite is genuine.
  • Different assays vary in their ability to detect it.

Test Studied

  • ARK Fentanyl II and Immunalysis SEFRIA

Source Lam et al., J Appl Lab Med 2024

What It Found

  • Two specimens from patients prescribed fentanyl were ARK-positive and FEN2-negative.
  • The authors found that different parent-drug and norfentanyl cutoffs affected detection.

Keep in Mind

  • The paper speculates about causes of unconfirmed positives but does not identify a responsible prescribed drug.

Test Studied

  • ARK Fentanyl II and Lin-Zhi FEN2 compared with LC-MS/MS

Source Wang et al., Forensic Sci Int 2011

What It Found

  • A historical 2 ng/mL urine HEIA was evaluated against LC-MS/MS.

Source Snyder et al., Clin Chim Acta 2011

What It Found

  • In a separate chronic opioid therapy cohort, Immunalysis HEIA detected 37 of 38 LC-MS/MS-positive urine specimens in the initial evaluation.

Source Chokkalla et al., EJIFCC 2025

What It Found

  • The authors classified positive fentanyl screens after labor epidural fentanyl as expected in their obstetric cohort.

Keep in Mind

  • The study was about confirmatory practice and did not confirm each epidural exposure separately.

Test Studied

  • Perinatal urine drug screening in a laboratory stewardship study

Source Wegner and Tiscione, American Academy of Forensic Sciences Annual Scientific Meeting, abstract K14 2015

What It Found

  • The same investigators' preliminary report found only 0.05–0.20% relative response to norfentanyl in fortified urine.

2 sources Tiscione and Wegner, J Anal Toxicol 2017 Wegner and Tiscione, American Academy of Forensic Sciences Annual Scientific Meeting, abstract K14 2015

Keep in Mind

  • This is evidence of weak recognition of a real metabolite on the studied reagent.

Test Studied

  • Neogen fentanyl RTU ELISA, 1 and 5 ng/mL urine decision points

Source Tiscione and Wegner, J Anal Toxicol 2017

Keep in Mind

  • Final-paper abstract does not give the individual percentages.

2 sources Wang et al., Forensic Sci Int 2011 Snyder et al., Clin Chim Acta 2011

Test Studied

  • Historical fentanyl urine homogeneous enzyme immunoassays, including Immunalysis HEIA

Suspected, but Not Proven

Ziprasidone

Source Waters and Tewksbury, J Am Pharm Assoc (2003) 2022

What It Found

  • A patient taking ziprasidone had an unexpected fentanyl screen.
  • The authors suspected ziprasidone because of the history and its structural relationship to risperidone.

Keep in Mind

  • The report does not establish reproducible cross-reactivity or document a definitive negative confirmation in the indexed abstract.

Test Studied

  • Emergency-department urine fentanyl immunoassay, platform unspecified in abstract

Iloperidone

Source HelloPharmacist. What Drugs Cause Fentanyl False-Positives?, 2022

What It Found

  • Our earlier answer on fentanyl false positives lists iloperidone.

Source Wang et al., J Anal Toxicol 2014

What It Found

  • The study usually cited for it tested risperidone and its active metabolite, 9-hydroxyrisperidone, on the DRI fentanyl screen, and reported no result for iloperidone.

Both sources HelloPharmacist. What Drugs Cause Fentanyl False-Positives?, 2022 Wang et al., J Anal Toxicol 2014

Keep in Mind

  • Iloperidone looks a little like risperidone in structure, but that alone does not show it affects the test.
  • We found no study that tested it on a urine fentanyl screen.

Test Studied

  • No iloperidone-specific clinical urine assay established in the reviewed sources

Tested: No False Positive Found

Alpha methylfentanyl

Source Mao et al., J Pharm Biomed Anal 2006

What It Found

  • The experimental antibody showed 5% relative response to Alpha methylfentanyl.

Keep in Mind

  • The abstract does not separately identify a urine matrix for the binding measurement.
  • This is analytical evidence for the antibody, not a patient result.

Test Studied

  • Experimental competitive anti-fentanyl ELISA evaluated for serum and urine

Lofentanil

Source Mao et al., J Pharm Biomed Anal 2006

What It Found

  • The experimental antibody showed less than 1% relative response to Lofentanil.

Keep in Mind

  • The abstract does not separately identify a urine matrix for the binding measurement.
  • This is analytical evidence for the antibody, not a patient result.

Test Studied

  • Experimental competitive anti-fentanyl ELISA evaluated for serum and urine

Remifentanil

Source Hightop Fentanyl/Norfentanyl Urine Rapid Test Panel and home-use panel, FDA 510(k)…, 2024

What It Found

  • Remifentanil did not produce a positive at the tested concentration of 20,000 ng/mL on this fentanyl line.

Test Studied

  • Hightop rapid urine panel, fentanyl line at 1 ng/mL

Source Wolf et al., Clin Biochem 2025

What It Found

  • None of the four reagents detected added Remifentanil in the study’s series tested at 1, 10 and 100 ng/mL.

Keep in Mind

  • This addresses the parent drug over the tested concentration range.

Test Studied

  • ARK Fentanyl II, Immunalysis Fentanyl Urine HEIA, Immunalysis SEFRIA, and Lin-Zhi Fentanyl II

Both sources Hightop Fentanyl/Norfentanyl Urine Rapid Test Panel and home-use panel, FDA 510(k)…, 2024 Wolf et al., Clin Biochem 2025

Keep in Mind

  • Other fentanyl analogues reacted differently, and other assays may give different results.
  • Results need not extend to other reagents or metabolites.